FRANKFURT— Bayer AG’s big push into the U.S. agrochemical market with its planned acquisition of Monsanto Co. could help it offset a growing problem on its home turf: increasingly stringent European regulation.
In an early step toward personalized medicine, a Jananese drug company, Daiichi Pharmaceuticals, is beginning clinical trails for a genetic test that would determine patients likely to suffer severe
China plans to use technical and scientific barriers to protect its local agricultural sector, state run media said. The report suggests that despite China's entry into the World Trade Organisation
Scientists at Johns Hopkins University say they have developed a noninvasive screening test that could sharply enhance doctors ability to detect a gene mutation that leads to colorectal cancer.
U.S. regulators gave the green light to the country's sole maker of the anthrax vaccine to resume shipments to government stockpiles, resolving years of federal concern about the vaccine's
Some of the most popular drugs in the U.S. lower cholesterol and reduce heart attack risk dramatically. As new government cholesterol standards could triple the number of people taking the drugs to
Poor and beset with the world's biggest tuberculosis epidemic, India seemed a perfect candidate for free TB drugs offered through the World Health Organisation. But over the past year, the WHO has
The Ottawa company caught the eye of investors in the late 1990 with its plans to manufacture heart-assist devices, which help failing hearts pump blood. Roderick M Brayden, World Heart chief
UTC Fuel Cells a unit of United Technologies Corp, signed a watershed agreement with Nissan Motor Co. to develop fuel-cell technology for future generations of automobiles.
Southeast Asia could become drier in the second half of this year due to a weak to moderate El Nino the Singapore government said, adding that it is hopeful the severe haze that plagued the region in
Trimeris Inc, a small U.S. drug developer and Roche Holding AG of Switzerland reported that an AIDS drug they are jointly developing showed a benefit for patients who weren't responding well to some
